BENDTSEN, J. D., H. NIELSEN, G. VON HEIJNE and S. BRUNAK, 2004 Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783-795.
CHAN, D., and L. L. NG, 2010 Biomarkers in acute myocardial infarction. BMC Med 8: 34.
CHANG, S. L., Y. W. HSIAO, Y. N. TSAI, S. F. LIN, S. H. LIU et al., 2018 Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure. J Mol Cell Cardiol 122: 69-79.
CHEN, D. Q., X. S. KONG, X. B. SHEN, M. Z. HUANG, J. P. ZHENG et al., 2019 Identification of Differentially Expressed Genes and Signaling Pathways in Acute Myocardial Infarction Based on Integrated Bioinformatics Analysis. Cardiovasc Ther 2019: 8490707.
CHRISTENSON, R. H., R. T. VOLLMER, E. M. OHMAN, S. PECK, T. D. THOMPSON et al., 2000 Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. Am J Cardiol 85: 543-547.
DE WINTER, R. J., R. W. KOSTER, A. STURK and G. T. SANDERS, 1995 Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. Circulation 92: 3401-3407.
EMANUELSSON, O., S. BRUNAK, G. VON HEIJNE and H. NIELSEN, 2007 Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2: 953-971.
GOBBI, G., C. CARUBBI, G. M. TAGLIAZUCCHI, E. MASSELLI, P. MIRANDOLA et al., 2019 Sighting acute myocardial infarction through platelet gene expression. Sci Rep 9: 19574.
KADOGLOU, N. P., D. K. TAHMATZIDIS, C. GIANNAKOULAS, A. KAPELOUZOU, A. GKONTOPOULOS et al., 2015 Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY. J Cardiovasc Med (Hagerstown) 16: 341-346.
KATAOKA, Y., R. SHIBATA, K. OHASHI, T. KAMBARA, T. ENOMOTO et al., 2014 Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J Am Coll Cardiol 63: 2722-2733.
LIAN, Z., F. F. LV, J. YU and J. W. WANG, 2018 The anti-inflammatory effect of microRNA-383-3p interacting with IL1R2 against homocysteine-induced endothelial injury in rat coronary arteries. J Cell Biochem 119: 6684-6694.
LIN, C. F., C. J. SU, J. H. LIU, S. T. CHEN, H. L. HUANG et al., 2019 Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats. J Clin Med 8.
LIU, N., F. ZHENG and X. ZHENG, 2018 Detection of biomarkers of acute myocardial infarction by high-throughput suspension array technology in serum sample. Bioanalysis 10: 47-58.
MENZEL, J., R. DI GIUSEPPE, R. BIEMANN, C. WITTENBECHER, K. ALEKSANDROVA et al., 2016 Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study. Atherosclerosis 251: 415-421.
MUSE, E. D., E. R. KRAMER, H. WANG, P. BARRETT, F. PARVIZ et al., 2017 A Whole Blood Molecular Signature for Acute Myocardial Infarction. Sci Rep 7: 12268.
NAGASAKA, A., C. MOGI, H. ONO, T. NISHI, Y. HORII et al., 2017 The proton-sensing G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) shows cardioprotective effects against myocardial infarction. Sci Rep 7: 7812.
OBUCHOWSKI, N. A., and D. K. MCCLISH, 1997 Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat Med 16: 1529-1542.
ORREM, H. L., C. SHETELIG, T. UELAND, S. LIMALANATHAN, P. H. NILSSON et al., 2018 Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction. Int J Cardiol 268: 187-192.
PARK, H. J., J. H. NOH, J. W. EUN, Y. S. KOH, S. M. SEO et al., 2015 Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction. Oncotarget 6: 12970-12983.
RAKOWSKI, T., A. DZIEWIERZ, J. LEGUTKO, P. KLECZYNSKI, A. BRZOZOWSKA-CZARNEK et al., 2014 Creatine kinase-MB assessed in patients with acute myocardial infarction correlates with cardiac magnetic resonance infarct size at 6-month follow up. Hellenic J Cardiol 55: 4-8.
SAFA, A., H. R. RASHIDINEJAD, M. KHALILI, S. DABIRI, M. NEMATI et al., 2016 Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease. Cytokine 83: 147-157.
SHIBATA, R., N. OUCHI, R. KIKUCHI, R. TAKAHASHI, K. TAKESHITA et al., 2011 Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 219: 811-814.
STEJSKAL, D., J. VACLAVIK, A. SMEKAL, G. SVOBODOVA, R. RICHTEROVA et al., 2016 Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 160: 219-221.
WANG, C., and Q. JING, 2018 Non-coding RNAs as biomarkers for acute myocardial infarction. Acta Pharmacol Sin 39: 1110-1119.
YABLUCHANSKIY, A., Y. MA, K. Y. DELEON-PENNELL, R. ALTARA, G. V. HALADE et al., 2016 Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization. J Gerontol A Biol Sci Med Sci 71: 475-483.
YAN, X., T. SHICHITA, Y. KATSUMATA, T. MATSUHASHI, H. ITO et al., 2012 Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc 1: e004408.
YU, G., L. G. WANG, Y. HAN and Q. Y. HE, 2012 clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16: 284-287.
ZDENEK VALENTA, I. M., MICHAL KOLAR, HANA GRUNFELDOVA, PETRA FEGLAROVA, J PELESKA, M TOMECKOVA, JAN KALINA, DALIBOR SLOVAK, J ZVAROVA, 2012 Determinants of excess genetic risk of acute myocardial infarction-a matched case-control study. European Journal for Biomedical Informatics 8: 34-43.
ZHANG, R., Z. JI, Y. QU, M. YANG, Y. SU et al., 2020 Clinical value of ARG1 in acute myocardial infarction patients: Bioinformatics-based approach. Biomed Pharmacother 121: 109590.
ZHAO, J., H. YU, P. YAN, X. ZHOU, Y. WANG et al., 2019 Circulating MicroRNA-499 as a Diagnostic Biomarker for Acute Myocardial Infarction: A Meta-analysis. Dis Markers 2019: 6121696.
ZHU, Y., C. HU, Y. DU, J. ZHANG, J. LIU et al., 2019 Time-Dependent Change in Omentin-1 Level Correlated with Early Improvement of Myocardial Function in Patients with First Anterior ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention. J Atheroscler Thromb 26: 856-867.